Just One MORE: Pilot study of a single-session, 2-hour version of Mindfulness Oriented Recovery Enhancement (MORE) for chronic pain patients

 

Project Description:

Our long term goal is to develop maximally effective brief MBIs that minimize both provider and patient burden.
This study’s overall objective is to use an effectiveness-implementation hybrid design to examine the feasibility, acceptability, and clinical benefits of One MORE – a single-session, 2-hour version of the traditional MORE intervention – for chronic pain patients.

 

Abstract:

Mindfulness is an effective treatment for chronic pain, but traditional mindfulness-based interventions, such as Mindfulness Oriented Recovery Enhancement (MORE) require a time and resource investment (i.e., eight, 2- hour sessions) too burdensome for many patients and providers. The solution may be to distill the most potent elements of the traditional MORE intervention into a brief, 2-hour, single-session intervention: One MORE. While a brief intervention may initially appear insufficient to treat a chronic condition, evidence from four recent randomized clinical trials suggests single-session, 15-20 minute, MORE-based interventions can have durable impacts on pain-related outcomes. This project will build on this previous work, using an effectivenessimplementation hybrid design (Type 1) to examine the feasibility, acceptability, and clinical benefits of One MORE for chronic pain patients. This project's central hypothesis is that teaching chronic pain patients (N=60) the core principles of MORE in a single, 2-hour intervention session will provide them with the pain management foundation to substantively improve their quality of life over time. To test this hypothesis we will pursue the following specific aims: Aim 1 seeks to demonstrate the feasibility and acceptability of One MORE for chronic pain patients; Aim 2 will test the effect of One MORE on pain-related outcomes (e.g., pain catastrophizing, pain intensity, pain interference, physical function) out to a three month follow-up; and, Aim 3 will determine whether changes in acute pain during the One MORE program predict improvement in painrelated outcomes. If the expected outcomes are observed, then we will have taken a critical step in the process of (a) retiring opioid medications as a first line treatment for chronic pain, and (b) developing behavioral interventions of graduated intensity to better match patient needs.

 

Blog Search